Lorelin Depot Injection
- Company Name:DongKook Pharm. Co., Ltd.
- Membership:Free Member
- Member Since:2003. 02.14
- Country/Region:Korea
- City:Chungcheongbuk-do
- Contact:Jisung Yun
- Related Keywords:Lorelin Depot Injection
Contact us
DongKook Pharm. Co., Ltd.
[Korea]
Description
Lorelin Depot Injection contains Leuprorelin acetate, LHRH analogue releasing
from hypothalamus.
Lorelin depot Injection is developed as a depot preparation of Leuprorelin acetate
using micro-encapsulated formulation demonstrated continuous release of the drug
for 4 weeks and the effective suppression of testosterone after a subcutaneous
injection monthly.
Ingredients
1 vial contains 3.75mg, 7.5mg of Leuprorelin acetate.
Indications
1. Prostatic Cancer
2. Endometriosis
3. Premenopausal Breast Cancer
4. Reduction of Myoma Nucleus and Improvement of Symptom in Uterine Myoma accompanied
with Hypermenorrhea, Hypogastriumache, Lumbago, Anemia
5. Central Precocious Puberty
Dosage and Administration
For further information, please see the insert.
Shelf life
3 years
Storage
Store at room temperature.
How supplied
3.75mg : 1 vial/Box
7.5 mg : 1 vial/Box
Other products from this supplier
Browse: Manufacturer Directory Countries China India Korea Premium Suppliers Community Site Map
About EC21 Contact Us Terms & Conditions Report Item Online Trading Risks Product Listing Policy
中文 繁體 한국어 日本語 Español Русский Français Deutsch
Copyright (c)1997-2024 EC21 Inc. All Rights Reserved. EC21 in KoreanChinese
Business Registry Number: 120-86-03931